| Literature DB >> 35965836 |
Qin Ding1,2, Wei Chen1,2, Chang Chen2,3, Yu-Ming Zhu2,3, Wei-Wei Yang2,3, Jun-Rong Ding2,3.
Abstract
Background: Lung transplantation is an effective treatment for saving the lives of patients with end-stage lung disease (ESLD). Lung transplant-related morbidity and mortality has significantly higher than other solid organ transplants. Among the pre-transplant variables that affect the survival rate after transplantation, nutritional status are associated with poor survival rate. In order to provide basis for formulating nutritional evaluations for lung transplant recipients in the future, we retrospectively analyzed the nutritional status of lung transplantation recipients and explore its correlation with the short-term prognosis.Entities:
Keywords: Lung transplant recipients; Nutritional Risk Screening (NRS); malnutrition; nutritional evaluation; prognosis
Year: 2022 PMID: 35965836 PMCID: PMC9372663 DOI: 10.21037/atm-22-3125
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Comparison of general data between the 2 groups of lung transplant recipients
| General data | Nutritional risk (n=16) | Normal nutrition (n=17) | P | |
|---|---|---|---|---|
| Sex (n) | 0.31 | 0.58 | ||
| Male | 13 | 15 | ||
| Female | 3 | 2 | ||
| Age (years), mean ± SD | 60.3±2.52 | 64.0±1.83 | 1.20 | 0.24 |
| Primary disease (n) | 8.55 | 0.07 | ||
| ILD | 7 | 13 | ||
| COPD | 7 | 2 | ||
| IPF | 0 | 2 | ||
| PAH | 1 | 0 | ||
| Silicosis | 1 | 0 | ||
| Operation methods (n) | 0.25 | 0.62 | ||
| Unilateral | 5 | 4 | ||
| Bilateral | 11 | 13 | ||
| Operation time (h), mean ± SD | 4.06±0.34 | 3.79±0.29 | 0.60 | 0.56 |
| ECMO (n) | 2.43 | 0.12 | ||
| Yes | 9 | 5 | ||
| No | 7 | 12 |
ILD, interstitial lung disease; COPD, chronic obstructive pulmonary disease; IPF, idiopathic fibrosis; PAH, pulmonary arterial hypertension; ECMO, extracorporeal membrane oxygenation.
Figure 1Preoperative nutritional status of the lung transplant recipients. NRS, Nutritional Risk Screening.
Comparison of indicators after lung transplantation between the 2 groups
| Indicators | Nutritional risk (n=16), mean ± SD | Normal nutrition (n=17), mean ± SD | P | |
|---|---|---|---|---|
| Serum albumin (g/L) | 34.4±1.21 | 39.7*±1.64 | 2.53 | 0.02 |
| Serum prealbumin (g/L) | 169±16 | 225*±17 | 2.39 | 0.02 |
| Retinol-binding protein (mg/L) | 20.1±1.96 | 25.7*±1.50 | 2.32 | 0.03 |
| Total lymphocyte count (×109/L) | 0.97±0.11 | 1.56*±0.23 | 2.30 | 0.03 |
| Calcium (mmol/L) | 2.16±0.04 | 2.30*±0.04 | 2.50 | 0.02 |
*, the difference is statistically significant compared to the nutritional risk group, P<0.05.
Comparison of clinical outcome-related indicators after lung transplantation between the 2 groups
| Indicators | Nutritional risk (n=16), mean ± SD | Normal nutrition (n=17), mean ± SD | P | |
|---|---|---|---|---|
| 24 h drainage (mL) | 750.0±94.1 | 521.1*±54.2 | 2.14 | 0.04 |
| ICU stay (d) | 23.4±2.32 | 21.8±2.30 | 0.48 | 0.64 |
| Hospital stay (d) | 57.56±6.78 | 40.59*±4.61 | 2.09 | 0.04 |
| Hospital costs (RMB) (ten thousands) | 46.9±1.76 | 41.1*±1.14 | 2.80 | 0.01 |
*, the difference is statistically significant compared to the nutritional risk group, P<0.05. ICU, intensive care unit.